Home » Newsletters » BioWorld Science

BioWorld Science

April 21, 2015

View Archived Issues

An attenuated, gD-deleted vaccine provides 100% protection against herpes simplex virus

Dose-escalation to proceed in phase I/II trial of Vivolux's iron chelator for cancer

Anika Therapeutics completes enrollment in repeat-injection study of Cingal

Combined use of cfDNA and CareDx's AlloMap to identify rejection in heart transplant recipients

Takeda initiates collaboration on identification and analysis of RNA-binding proteins

Panther licenses rights to TDZD-8 from University of Rochester

BNC-210 enters phase II evaluation for anxiety

Expedited development of lonafarnib with ritonavir for hepatitis D virus infection

Lilly reports phase III trial success with ixekizumab

CiRA and Takeda to collaborate on drug discovery using iPS cells

Mallinckrodt seals the deal with Ikaria

Brain cancer collaboration between Novogen and the Feinstein Institute announced

Ampio reports results from phase III trial STRIDE of Ampion in OA

SAGE Therapeutics initiates phase III expanded access study of SAGE-547 in SRSE

Sumitomo Dainippon Pharma reports mGlu5 receptor modulators

Polish scientists develop mGlu4 PAMs

PPARalpha antagonists hold promise as a complement to chemotherapy for pancreatic cancer

Paclitaxel trevatide named orphan drug in the U.S.

ZV-0201, an ADC for the treatment of HER2-positive cancers

University of California, Oakland presents integrin alphavbeta1 antagonists for fibrosis

Potent ADAM 17 antibody inhibits tumor growth

Vertex develops inhibitors of PAR2 signaling pathway

MBX-8025 receives FDA orphan status for Frederickson Type I or V hyperlipoproteinemia

Tamoxifen found to inhibit the effects of amphetamine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...